At Centrum Pharmacy, we believe that therapeutic products belong where therapy is managed—in the pharmacy.
Today, Canadians are using billions of dollars’ worth of medical cannabis—without pharmacist oversight. As Health Canada proposes a new pathway for CBD health products, we have a rare opportunity to restore pharmacy’s rightful role in cannabinoid care.
Why it matters:
- CBD can interact with medications like warfarin and methotrexate—yet patients are left to self-navigate.
- Pharmacists already manage nicotine, natural health products, and even veterinary meds. Why not CBD?
- Moving CBD behind the counter, with pharmacist guidance, ensures safe, informed use—and integrates cannabinoid therapies into a patient’s care record.
This isn’t about profit. It’s about patient safety, continuity of care, and professional responsibility. If we cede this space again, we risk being excluded from future therapeutic categories, from psychedelics to gene therapies.
Health Canada’s consultation closes June 5, 2025.
Let’s not miss our second chance.
Need guidance on medical cannabis?
We don’t sell cannabis—but we can help you understand if it’s right for you. Our pharmacists can refer eligible patients to specialized cannabis clinics as part of a safe, informed treatment plan.
Visit our Cannabis Referral Page to learn more about our referral process and how we ensure care continuity.
Disclaimer: The medical information on this site is provided as an information resource only and is not to be used or relied on for any diagnostic or treatment purposes. This information does not substitute for professional diagnosis and treatment. Please do not initiate, modify, or discontinue any treatment, medication, or supplement solely based on this information. Always seek the advice of your healthcare provider first. Full Disclaimer.
